Home / Central Data Catalog / TASP / ANRS12249TASP / variable [F74]
tasp

Treatment as Prevention ANRS 12249

South Africa, 2012 - 2016
Get Microdata
Reference ID
ANRS12249TasP
Producer(s)
Dabis, François, Newell, Marie-Louise, Pillay, Deenan
Collections
TasP ANRS 12249
Metadata
Documentation in PDF DDI/XML JSON
Created on
Jan 30, 2018
Last modified
Jan 30, 2018
Page views
394627
Downloads
4610

According to the physician, is this SAE related to any causes other than the research? If yes, describe (SAECausedByOtherDesc)

Data file: SAEs Initial Notifications

Overview

Valid: 213
Type: Discrete
Width: 244
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
Abdominal LFT's present at baseline. Patient is also hepertitis B POSITIVE. 1
0.5%
Abnormality present at baseline 1
0.5%
Accident 1
0.5%
Acute cholecystitis,abdonrmal liver function test was present prior to enrolment. 1
0.5%
Acute gastro enteritis causing Pre-renal failure, exacerbated by tenofavir. 1
0.5%
Adequate information on circumstance of death not available. 1
0.5%
Advance HIV Multy-Drug resistant TB 1
0.5%
Advanced HIV 1
0.5%
Advanced HIV + Poor ART Adherence resulting in probable Pulmonary TB. 1
0.5%
Advanced HIV dicease 1
0.5%
Advanced HIV diseased with suspected pulmonary TB 1
0.5%
Advanced HW in patient who interrupted treatment on multiple occasion 1
0.5%
Advanced retroviral dicease at baseline clinic visit. 1
0.5%
Alcohol abuse, present at baseline 1
0.5%
Anaemia of chronic decease 1
0.5%
Anaemiawas noted on baseline blood results 1
0.5%
Anemia of Chronic disease 1
0.5%
Any patient is at rish of being involved in an accident, regardless of partipant in research 1
0.5%
Any patient is susceptible to mentakl health illness or to commit suicide. It does not appear that the trial was related to this event. 1
0.5%
Anybody is at risk of psychiatric illness. More information will follow once patient isd reviewed + diagnosis elicited. 1
0.5%
Baseline revealed Hepatitis BsAg positive . Further information not available 1
0.5%
CA Cervix predated enrolment in Trial 1
0.5%
Cancer of the cervix 1
0.5%
Cause of death is unclear 1
0.5%
Cause of death unknown.Patient reported to have been unwell. 1
0.5%
Cause of severe abdominal pain & vomitting still being investigeted. 1
0.5%
Cellulitis present at baseline clinic visit 1
0.5%
Chronic GI Problem-need futher investigation (different diagnosis bowel TB,paitsistic infection malicvancy) 1
0.5%
Chronic lung deceases - Sequela of Previous TB decease 1
0.5%
Complication of breast feeding 1
0.5%
Decompensated Alcoholic liver dicease with cirrhosis. 1
0.5%
Diagnosis unknown . Patient has only been seen once at baseline . 1
0.5%
Diarrhoea resulting in acute renal failure. Deep vein thrombosis 1
0.5%
Discharged on fluconazole , Probably for hyptococcal meningitis . Will need confirmation . 1
0.5%
Elevation of GGT/LFTs was already present at baseline 1
0.5%
First trimaster miscarriages are very common 1
0.5%
First trimester miscariage 1
0.5%
From relatives. Patient seemed tohave been unwell, resulting in admission of death. 1
0.5%
GGT started rising whilst patient was on D4T/3TC/EFV before joining the research . 1
0.5%
GGT was adnormal at baseline but has gradually gotten worse, starting on Atripla/ Herbal remedies/ alcohol. 1
0.5%
Gall stones 1
0.5%
Gastroenteritis 1
0.5%
HIV opportunistic inffection 1
0.5%
HIV patient on ART's anol PTB treatment 1
0.5%
HIV positive patient,l on Art - susceptible to TB MZDR. TB highly prevalant in subdistrict 1
0.5%
Had Menorrhagra dummy the last Menstrual period. 1
0.5%
Has been I Tasp on Atripla sine 2013 withat prior advvese events . Deranged LFT likely due to an extenal case . 1
0.5%
High risk of malnutrition due to immunosuppression 1
0.5%
High viral load despite prolong ARV use , amotype slims resistance to EFV and 3TC . 1
0.5%
Hiluly to be related to alcohol consumption 1
0.5%
History Incomplete 1
0.5%
Iron deficiency anaemia, cause not yet identified. 1
0.5%
Known HPT/CCF/Chronic renal failure 1
0.5%
LFT's including GGT with grade 3 abnormalities at baseline due to alcohol abuse. 1
0.5%
LT Upper Zone PNeumonia , To Exclude Pulmonary TB Peptic ulcer disease . 1
0.5%
LTS's abnormal at baseline synerstic synergistic toxiaty from Atripla + Alcohol + herbal remedies 1
0.5%
Likely to be worsering curonic kidney Disease due to Hypertension but coud Also be HIV - Associated Nepuropathy . 1
0.5%
Lower Respiratory Trect Infection 1
0.5%
Most likely cause of deranged LFT is alcohol. 1
0.5%
Multiple ART defaults, cannot exlude bone narrow suppression from Cotrimaxazole 1
0.5%
Multy-Drug resistant treatment. 1
0.5%
Normocytic anaemia, requires further investigation. 1
0.5%
Not enough information 1
0.5%
Not on ART in Control cluster and not eligible for ART but returned after 6months and found eligible under new guidelines. Currently not on ART. 1
0.5%
Participant already had TB symptoms at baseline. 1
0.5%
Participant default ed flucconazole, at rist of recurrent cryptococcal meningitis 1
0.5%
Participant defaulted anti - epileptic treatment and thus had siezures 1
0.5%
Participant diagnosis with throat cancer 1
0.5%
Participant found to be Anaemia at baseline visit. 1
0.5%
Participant had dirrhoea, admitted use of herbal medicines and had been nephrotoxic medication. 1
0.5%
Participant had stroke at a young age. She is still undergoing investigation. HIV stroke may be contributing 1
0.5%
Participant has Malnutrion and severe wasting with low CD4 count. He is highly susceptible to infections 1
0.5%
Participant has cervical cancer 1
0.5%
Participant has history of alcohol abuse which is likely to account for raised liver enzymes. 1
0.5%
Participant is hypertensive - risk of renal failure is high. Nephrotoxic treatment also may add to severity 1
0.5%
Participant most likely has iron deficiency anaemia 1
0.5%
Participant newly diagnosed with PTb May have disseminated TB strong hstory of cannibis use 1
0.5%
Participant severely immunosuppressed with PTB. Exact cause of death not yet known. 1
0.5%
Participant surely immunocompromised upon enrolment. Supected TB IRIS. 1
0.5%
Participant susceptible to TB due to immunosuppression. 1
0.5%
Participant unknown with Bipoal mood disorder - is prone to relapsed acute episodes. 1
0.5%
Participant using herbal medicines for Sangoma initiation. At risk of nephiotoxity 1
0.5%
Participant was assaulted 1
0.5%
Participant will longstanding history of severe illness, failed to go to hospital with cormobid HIV and extrapulmonary TB. 1
0.5%
Participant with advances HIV and TB. Needs to be invesitgated to exclude dissiminated or resistant TB. 1
0.5%
Participant with declining CD4 count very suscetible to oppotunistic infections. 1
0.5%
Participant with evidence of treatment failure, no clinical improvement. Has co-morbid TB and HIV. Very ill. 1
0.5%
Participant with history of incorrect dosing of ART. Also previously on NVP which may caused liver toxicity. 1
0.5%
Participant with uncontrolled diabetes , at risk of renal failure 1
0.5%
Participant with very low CD4, not on ART, developed acute renal failure from diarrhoea. 1
0.5%
Participants was injured 1
0.5%
Participantwith very low CD4 succeptable to oppotunisic infections. 1
0.5%
Partiocipant succestible to TB due to immunosuppresion. 1
0.5%
Patient ART naïve and not prescribed any drugs within trial 1
0.5%
Patient LFT's are demaged at baseline entry into TasP 1
0.5%
Patient at risk of cancer regardless of participation in research 1
0.5%
Patient at risk of diarrhoea as imnosuppressed and on Aluvia. Unrelated to research 1
0.5%
Patient committed suicide, the reason for thi is unknown. 1
0.5%
Patient complained of weight loss and dry cough recently . 1
0.5%
Patient developed panariatitis most likely from an acute which is still being investigated. 1
0.5%
Patient developes severe diarrhoea and Acute renal failure prior to Atripla Reveles by blood test done on same day started Atripla. Atripla could have exacerbated the acute renal failuere 1
0.5%
Patient did not go to hospital when referred. She most likely had TB. 1
0.5%
Patient died in his sleep cause unknown. 1
0.5%
Patient extremely immunosuppressed 1
0.5%
Patient had been on ART fkor long period of time before having psychotic episode. 1
0.5%
Patient had breast cancer the trial unfortunately it has progressed 1
0.5%
Patient had deranged LFT prior 0to TasP likely alcohol is the main contributor 1
0.5%
Patient had longstanding history of abdnormal bleeding and had defaulted ART. 1
0.5%
Patient had longstanding history of undiagnored depression which complicated with psychosis 1
0.5%
Patient had variable blood sugar readings over time at Tasp clinics. Was at risk of type 2 diabetes. 1
0.5%
Patient has been to Tasp for 9 months. Only returned now as he is sick. 1
0.5%
Patient has multiple myeloma + on naproxen 1
0.5%
Patient has multiple risk factors for derange LFT's. 1
0.5%
Patient immuno 1
0.5%
Patient immunocompromised . At rish of multiple causes of confusion . 1
0.5%
Patient immunosuppressed, prone to apportunities infections. 1
0.5%
Patient is HIV POSITIVE WITH CHRONIC ANAEMIA. Need amement 1
0.5%
Patient is HIV positive, on ART prior to Tasp. Came of LFT deranged unclear ar present. 1
0.5%
Patient is diabetic,hypertensive and HIV positive which mascles him susceptible to multiple infections. 1
0.5%
Patient is imiunocompromised +atrisk of infection 1
0.5%
Patient is immcompromised with incresed risk of gastroentritis. Risk of dehydration is high with gastroentrities 1
0.5%
Patient is immnocompromised. At risk of TB 1
0.5%
Patient is immnosupressed, At risk of GE 1
0.5%
Patient is severely immunocompromised + at risk of abcsess 1
0.5%
Patient most likely had prostate cancer. PSA was 57 and patient was symptomatic 1
0.5%
Patient must have suffered from dehydrated to vomiting exacerbated by tenofavir + hydrocithorothiazide 1
0.5%
Patient must likely had cervical cancer 1
0.5%
Patient newly diagnosed with TB. She is 1
0.5%
Patient severely ill with co-morbid MDR-TB and advanced AIDS desease 1
0.5%
Patient transfered in at baseline with Hb 6.1 1
0.5%
Patient transferred in with this problem. 1
0.5%
Patient was already on TDF which could be a cause orcontributing factor to this renal failure, fixed doze ARV's stopped. 1
0.5%
Patient was already on antiretroviral drug before joining the research . 1
0.5%
Patient was immnocompromised + side at entry into the trial 1
0.5%
Patient was immunocompromised and known to Abuse alcohol . 1
0.5%
Patient was immunoconipromised with a possible TB ccontact, so was high risk of TB 1
0.5%
Patient was known with congestive cardiac failure. He had defaulted treatment and not disclosed to trail clinic 1
0.5%
Patient was on long term asprin prior to Tasp study. 1
0.5%
Patient was severely immunocompromised. Alluvia can cause diarrhoea, but patient was complinity of diarrhoea before switching to Alluvia. 1
0.5%
Patient with PTB, succeptable to superimposed bacterial infection 1
0.5%
Patient with advances HIV, poor compliance and pulmonary TB 1
0.5%
Patients age and immune status are risk factors fo cancer. 1
0.5%
Pelvic inflammatory disease 1
0.5%
Physical /Sexual Assault 1
0.5%
Pnevious TB Episodes ( 2007/2008 ) 1
0.5%
Poor adherence to ART mth multiple stops restarts possibly IRIS 1
0.5%
Possibly a combination of Stavudine treatment , Alcohol and Hepatitis B . 1
0.5%
Possibly related to Advanced HIV infection. Patient also anemic with weight loss. 1
0.5%
Pre - existing abnormality in YGT, Whilst on D4T/3TC/EFV. Need to obtain alcohol history. 1
0.5%
Predated the reseach . 1
0.5%
Present at baseline with renal failure. Post discharge drug will be ratranalised 1
0.5%
Present at baseline. 1
0.5%
Previous TB,possibly bronchiectasis.Alcohol abuse. 1
0.5%
Probable Iron deficiency Anaemia 1
0.5%
Probable Iron deficiency anemia present at baseline 1
0.5%
Probable Pulmonary TB 1
0.5%
Probable iron Defigency Anaemia 1
0.5%
Probable iron deficiency.Anaemia 1
0.5%
Probable iron definancy anaemia presental baseline 1
0.5%
Probably Haemorrhoids 1
0.5%
Probably alcohol abuse although HAART can cause elevate GT . 1
0.5%
Probably alcohol abuse. 1
0.5%
Probably alcohol related elevation of gamma glutamyl transference.Efavirenz was prescribed before participation in reseach. 1
0.5%
Probably iron deficientcy Anaemia 1
0.5%
Probably iron deficiency anaemia. 1
0.5%
Probably related to Alcohol abuse 1
0.5%
Propable TB,L Presented of baseline 1
0.5%
Pt had familly CD4 count and cough she may have had TB which was not investigated. She also had social stressor. 1
0.5%
Pt on ART for a long time. Confusion is acute with PTB being diagnosed. C7 brain is important to exclude space occupying lesion in the brain 1
0.5%
Pt with multiple episode pulmonary TB susceptible to dyspnoea due to lung fibrosis 1
0.5%
Pt with underlying autommune disease . She recovered quickly from psychosisdespite not being on treatment & is still on Atripla . 1
0.5%
Pulmonary TB 4
1.9%
Rirely due to taking tenofovir , which she commenced prior to enrolling at TASP . No previus renal past medlet history 1
0.5%
Severe diarrhoea and renal failure pre - dated baseline clinic visit. Severe diarrhoea must have resulted in Pre renal failure with additional neuphrotixicty from Tinofavir 1
0.5%
Severe gastroenteritis resulting in acute renal failure exacerbated bytenofovir prescribed before joining trisil 1
0.5%
Stabbed abdomen 1
0.5%
Stroke 1
0.5%
Tdhis patient is Immnocompromised would have been at risk of pneumonia / sepsis regarden of participant in Tasp. 1
0.5%
The parent had proven pulmonary tuberculosis 1
0.5%
The patient died of a presumed urinary truck infetion cammy sepsis,although she was not referred for past- mortem 1
0.5%
The patient has HIV and is at risk of opportunistic infections. 1
0.5%
The patient is at risk of gastroentertis due to immunoconipromise 1
0.5%
The patient was already on TB treatment prior to enrolment in TasP. 1
0.5%
The patient was imminospprened and at risk of oppotunistic infection. 1
0.5%
The patient was immonoscomposed and at risk of aopportunist infection. 1
0.5%
The patient was immunosuppressed and at risk of infection 1
0.5%
The patient was on D4T prior to Tasp but started TDF April 2013 + was stable until this point 1
0.5%
The patient was pregnant + at risk of complaications in research. 1
0.5%
The putient was aneemia before entry into Tasp. Women with HIV are at high risk of cervical cancer 1
0.5%
This patient had HIV and hypertension. Participation is research did not alter the cure 1
0.5%
This patient had microcytic anaemia prior to joining TasP + was investigated for fibrods 1
0.5%
This patient is immnosupressed + at risk of TB + fustro enteritis regardless of participant in Tasp. 1
0.5%
This patient joined Tasp already pregnant + anaemia 1
0.5%
This patient was immunocumpoused and at rsk of TB or TB IRIS 1
0.5%
This patient was killed. There is no relation to this research 1
0.5%
This putient came into the trial with this problem . 1
0.5%
This putient is severely immunosuppressed and prior to hospitaliseted was Art naïve which put him at risk of these events 1
0.5%
Thyroat cancer 1
0.5%
Treatment interruption advanced HIV 1
0.5%
Unable to comment 1
0.5%
Uterine Prolapse coused Hospitalisation for a hysterectomy 1
0.5%
advanced HIV desease tuberculosis 1
0.5%
other differential diagnoses under investigation. Has risk factors for cerebral vascular disease 1
0.5%
patient had diarrhoea for 1 month which could account his renal impaitment . 1
0.5%
patient in immunocompromised . At risk of Infection 1
0.5%
patient is immunocompromised at rish of infection + abscesses 1
0.5%
patient is known to drink alcohol to excn . This is unrelated to the trial 1
0.5%
severe hypochronic anemia 1
0.5%
the patient is immunocomromised and at risk of gastiventertis 1
0.5%
unable to comment 1
0.5%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog